As of: April 9, 2025
99.76%
Batch-to-batch consistency
38.5%
Lower Error Rate
(Oligo Synthesis)
2.84x
Higher Yield
(Recombinant Protein)
31.8%
~sustained below market price
All performance metrics are backed by internal validation and benchmarking studies. If you’d like to review the data, please don’t hesitate to request the full report !
Versatility & Automation in Action
We’ve re-engineered synthesis manufacturing to be modular, intelligent, and highly adaptable. Whether producing complex oligonucleotides or precision proteins, our platform combines automation, real-time analytics, and AI-driven optimization to deliver seamless scalability and unmatched flexibility. From rapid prototyping to GMP-ready production, we empower teams to move faster, pivot effortlessly, and manufacture with confidence.
Solid-Phase Nucleotide Synthesis
Smarter Chemistry. Longer Strands. Cleaner Builds.
List of Services
-
Microfluidic PrecisionList Item 1
We miniaturize synthesis environments to reduce reagent use, increase speed, and enable parallel production of complex sequences.
-
Enzymatic Hybrid SynthesisList Item 2
By integrating enzymatic steps into traditional chemical workflows, we extend sequence length and improve purity—without compromising efficiency.
-
Real-Time Process AnalyticsList Item 3
In-line UV-Vis and mass spectrometry tools monitor every coupling step, enabling adaptive control and higher fidelity.
-
AI-Optimized Sequence DesignList Item 4
Our proprietary algorithms predict synthesis bottlenecks and optimize routes to minimize truncation and maximize yield.
-
Sustainable Chemistry
We replace harsh solvents with greener alternatives, reducing environmental impact and improving safety.
Our next-generation SPNS platform redefines what’s possible in oligonucleotide synthesis:
Outcome:
Faster synthesis, longer oligos, and cleaner products—ready for scale.
Host Cell Protein Expression
Engineered Cells. Predictable Yields. Scalable Systems.
List of Services
-
Minimalist Chassis CellsList Item 1
Our synthetic host strains are stripped of non-essential genes, reducing background protein expression and simplifying purification.
-
CRISPR-Tuned ExpressionList Item 2
Dynamic gene regulation using CRISPRa/i allows us to fine-tune expression levels in real time—maximizing productivity without stressing the system.
-
Cell-Free PrototypingList Item 4
For toxic or complex proteins, our cell-free systems offer rapid expression and precise control over reaction conditions.
-
Machine LearningList Item 3
Predictive models guide media formulation, induction timing, and harvest points—reducing trial-and-error and accelerating scale-up.
-
Continuous Bioprocessing
We’ve moved beyond batch. Our perfusion-based systems enable stable, high-density cultures with consistent output.
We’ve reengineered protein expression from the ground up to deliver high-yield, low-noise biomanufacturing:
Outcome:
Cleaner proteins, faster timelines, and scalable production from lab to GMP.
Cross-Platform Enhancements
Digital-First, Modular, and Built for Scale
List of Services
-
Digital TwinsList Item 1
Every process is mirrored in a virtual model, enabling simulation, optimization, and predictive control before a single drop is synthesized.
-
Modular Manufacturing UnitsList Item 2
Our plug-and-play systems allow rapid reconfiguration for new products, reducing downtime and accelerating tech transfer.
-
Crypted TraceabilityList Item 3
From raw materials to final product, every step is logged and secured—ensuring transparency, compliance, and data integrity.
Our platform is more than chemistry and biology—it’s a digital ecosystem designed for agility and traceability:
Outcome:
A smarter, more responsive manufacturing environment—built for the future of personalized and precision medical research..
Biomarker Analysis
Cell Biology
Characterization
Purification
